Nanostring GeoMx

The nanoString® GeoMx platform supports quantitative analysis of proteins, phospho-proteins and mRNAs from user defined cell populations across sections of FFPE tumor tissue. The Knight Cancer Institute is a designated Center of Excellence for GeoMx applications and is working closely with nanoString in the development and validation of new biomarker targets. Over 100 proteins and 1,800 mRNAs can be rapidly analyzed with this technology.